NEW YORK (1010 WINS) -- Pfizer, Moderna, Johnson & Johnson, and soon there may be others like – AstraZeneca or Novavax. They are all different types of vaccines mass-produced to end the COVID-19 pandemic.
All of them have trigger immune responses in our bodies to protect us from the coronavirus, and each of them is different, but do you know why?
On this episode of In Depth, 1010 WINS reporter Al Jones discusses vaccines with Dr. Jeffrey Carson, a professor of medicine at Rutgers Robert Wood Johnson Medical School and principal investigator at Rutgers for the Johnson & Johnson trial. He's also joined by Dr. David Hirschwerk, the interim chair of the department of medicine and infectious disease at Northwell Health System.
Like 1010 WINS on Facebook and follow @1010WINS on Twitter to get breaking news, traffic, and weather for New York City.
Related
Related
